In February 2024, at the Tandem Blood and Marrow Transplantation Annual Meeting in San Antonio, USA, Professor Huang Xiaojun received the Distinguished Service Award from the Chair of the Center for International Blood and Marrow Transplant Research (CIBMTR). The spotlight focused on the Five-Star Red Flag badge on his chest. At this moment, it has been exactly twenty years since he first challenged the "gold standard" of hematopoietic stem cell transplantation.
In 2010, in the hematology ward of Beijing People's Hospital, 14-year-old leukemia patient Xiaolin faced a harsh reality: the Chinese Marrow Donor Program failed to find a match, there was no sibling donor in the one-child family, and the parental match was only haploidentical. At that time, the global medical community firmly believed that HLA full matching was the iron law for successful transplantation, and the three-year survival rate of haploidentical transplantation was less than 20%.
The half-century predicament was thus broken:
• 1970s: The first successful sibling full-matched transplantation was achieved, but it pushed patients without matching family members into a desperate situation
• 1990s: Europe and the United States explored T-cell-depleted haploidentical transplantation, but the infection and recurrence rates were as high as 60%
• Turning point in 2000: Huang Xiaojun's team discovered the phenomenon of G-CSF-induced immune tolerance — after donors were injected with G-CSF, T cells transformed from "attack mode" to "peace messengers"
This discovery gave birth to the revolutionary Beijing Protocol:
When 50% matched stem cells from Xiaolin's father flowed into his son's body, the heart rate curve on the monitor was like a roller coaster passing through a tunnel. Three years later, the good news that Xiaolin was admitted to medical school was hung in the corridor of the Institute of Hematology — he was the 3000th haploidentical transplant patient saved by the Beijing Protocol.
In 2017, the cover of the top international journal Leukemia was like a thunderbolt in the hematology community. Based on 1199 transplant data, Huang Xiaojun's team proposed a new donor selection rule:
"Donor-recipient age difference < 30 years, male donor, and ABO blood type compatibility are better predictors of survival than HLA full matching"
Risk Factors | Score | 3-Year Survival Rate | Mortality Risk |
Large age difference (>30 years) | +1 | 74%→58% | ↑173% |
Female donor to male recipient | +1 | ||
ABO blood type incompatibility | +1 |
Typical case: If a middle-aged male patient has an HLA fully matched sister with ABO blood type incompatibility, his ABO-compatible son (haploidentical) is actually a better donor! This discovery completely shook the "HLA 迷信" in transplant medicine.
Indicator | Traditional Protocol (2000) | Beijing Protocol (2024) | Progress |
3-Year Survival Rate | 20% | 70% | ↑250% |
Donor Accessibility | 25% | 100% | Full coverage |
Transplant Waiting Time | 12-18 months | 1-3 months | 80% reduction |
Data source: 2024 Annual Report of the Center for International Blood and Marrow Transplant Research
In 2022, data from the Asia-Pacific Blood and Marrow Transplantation Group (APBMT) showed that China's haploidentical transplantation volume accounted for 66% of the world's total, with an annual completion volume exceeding 4000 cases, 8 times that of the United States and 5 times that of Europe. The technical key of the Beijing Protocol lies in:
1. G-CSF: Induces Th2 cell differentiation and inhibits graft-versus-host disease
2. ATG: Precisely clears activated T cells with dose-dependent immune regulation
3. Combined bone marrow/peripheral blood infusion: Regulatory T cells and stem cells are co-implanted
After adopting the Beijing Protocol, the survival rate of haploidentical transplantation at the Rome Transplant Center in Italy jumped from 31% to 68%; Seoul National University Hospital in South Korea has made it the first choice for pediatric transplantation. As CIBMTR Chair Michael Verneris said: "The Beijing Protocol has become the most widely used and effective haploidentical transplantation system in the world".
In 2024, at Aga Khan University Hospital in Pakistan, doctors were facing more severe challenges:
Among 20 children undergoing haploidentical transplantation,
45% developed severe infections,
30% developed GVHD,
and the transplantation-related mortality rate reached 25%
This reveals the difficulties in the globalization of haploidentical transplantation:
• Resource constraints: Low- and middle-income countries lack sterile wards and antifungal drugs
• Technical threshold: Immune regulation doses need to be adjusted according to ethnicity
The Chinese protocol is evolving:
• CAR-T bridging transplantation: Clears minimal residual leukemia, reducing the recurrence rate to 12%
• Epigenetic regulation: HDAC inhibitors reshape T cell function, reducing GVHD risk by another 40%
• Portable bioreactor: Prepares stem cells at the bedside to solve transportation problems
Huang Xiaojun predicted in The Lancet-Haematology: "By 2035, haploidentical transplantation will achieve the 'three-zero goal': zero GVHD, zero infection, and zero recurrence".
In the early morning light at the Institute of Hematology, Peking University People's Hospital, nurses were collecting stem cells from the father of a Mongolian child. In the incubator, CRISPR-edited CAR-T cells glowed faintly — these cells would transform into "intelligent guards" after transplantation to eliminate residual cancer cells.
On the world map at the end of the corridor, the global footprint of the Beijing Protocol is marked: from Milan, Italy to Karachi, Pakistan, from Tokyo, Japan to Paris, France. Huang Xiaojun stroked the map and said softly: "When donor selection changes from 'looking for a needle in a haystack' to 'accessible relatives', we have fulfilled the promise that 'everyone has a transplant donor'".
Medical Notes
"Today, I completed a father-to-daughter haploidentical transplantation for a Burmese child. When the stem cell suspension was being infused, the blood bag shone like a ruby under the light. I remembered the father who knelt and begged twenty years ago: 'My daughter and I are only half-matched, but my love is 100%' — this is perhaps the spiritual core of the Beijing Protocol."
— Excerpt from Huang Xiaojun's surgical log
EN
CN